Skip to main content
Log in

Spectrophotometric quantification of astemizole and its demethylated metabolite in urine after TLC separation

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The coupling of TLC and UV measurement for determination of astemizole and its main metabolite, O-demethylated derivative, in urine has been investigated. The metabolite like the drug absorbs maximally at almost the same wavelengths, which makes their simultaneous UV determination in biological fluids quite inapplicable. TLC separation on silica gel F254 utilizing chloroform/methanol (85∶15, v/v) achieved the best fractionation of the two compounds from the matrix-components of urine. Concentration levels of 0.5–140 (μg/ml (ppm) in worked-up sample could be reached by adopting the spectrophotometric measurements at 286 nm for ethanolic extracts of the silica layers carrying each individual compound against a blank silica. Varying levels of the intact drug and its phenolic primary metabolite could be accurately traced in urine samples following a 10 mg single oral dose (∼12.5 μg/kg) after different time intervals up to 12 h. Synthetic preparation of the metabolite by demethylating astemizole is mentioned and its physicochemical characterization is briefly discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Van-Wauwe J., Awouters F., Niemegeers C., Jarnsens F., Van-Nueten J., Janssen P.A.J. (1981):In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound. Arch. Int. Pharmacodyn., 251, 39–51.

    PubMed  CAS  Google Scholar 

  2. Kistenansky P.M., Cluston R.J. (1987): Astemizole; A long-acting, nonsedating antihistamine. Drug Intell. Clin. Pharmacol., 21, 947–953.

    Google Scholar 

  3. Neuldermans, W., Hendrick J., Lauwers W., Hurkmans R., Swysen E., Heykams J. (1982): 8th European Workshop on Drug Metabolism, Liège, cf. ref. 6.

    Google Scholar 

  4. Hendricks R., Michiels M., Geuens L., Heykants J. (1981): Janssen Research Products Information Service, cf. ref. 6.

    Google Scholar 

  5. Sadana G.S., Potdar A.J. (1989): High-performance liquid chromatographic determination of astemizole in pharmaceutical dosage forms. Ind. Drugs, 27, 140–142.

    CAS  Google Scholar 

  6. Woestenborghs R., Embrechts L., Heykants J. (1983): Simultaneous determination of astemizole and its demethylated metabolite in animal plasma and tissues by high-performance liquid chromatography. J. Chromatogr. (Biomed. Appl.), 278, 359–366.

    Article  CAS  Google Scholar 

  7. Xinyi N., Liyi H., Zhihong R., Zhenyu S. (1985): Metabolic fate of quinghaosu in rats; A new TLC-densitometric method for its determination in biological materials. Eur. J. Drug Metab. Pharmacokinet., 10, 55–59.

    Article  Google Scholar 

  8. Abdel-Moety E.M., Al-Obaid A.M., Jado A.I., Lotfi E.A. (1988): Coupling of TLC and UV-measurement for quantification of naproxen and its main metabolite in urine. Eur. J. Drug Metab. Pharmacokinet., 13, 267–271.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Deeb, O.A., Abdel-Moety, E.M., Bayomi, S.M. et al. Spectrophotometric quantification of astemizole and its demethylated metabolite in urine after TLC separation. European Journal of Drug Metabolism and Pharmacokinetics 17, 251–255 (1992). https://doi.org/10.1007/BF03190156

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190156

Keywords

Navigation